Roberts Glore & Co. Inc. IL purchased a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, Holdings Channel.com reports. The fund purchased 6,037 shares of the company’s stock, valued at approximately $776,000.
Several other large investors have also bought and sold shares of MKGAF. Legal & General Group Plc purchased a new position in Merck KGaA during the 2nd quarter worth $2,425,225,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in shares of Merck KGaA in the second quarter valued at about $942,087,000. Canada Pension Plan Investment Board bought a new position in shares of Merck KGaA during the second quarter valued at about $536,694,000. Jupiter Topco LLC purchased a new position in Merck KGaA during the second quarter worth about $501,199,000. Finally, Bank of Nova Scotia purchased a new position in Merck KGaA during the second quarter worth about $281,696,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Trading Up 0.3%
Shares of MKGAF stock opened at $164.00 on Wednesday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The company has a market capitalization of $21.20 billion, a price-to-earnings ratio of 25.04 and a beta of 0.96. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company has a 50-day simple moving average of $163.08 and a two-hundred day simple moving average of $148.69.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
